Condensed Statements of Changes in Stockholders’ Deficit (Unaudited) - USD ($)

Preferred Stock

Series A

Common Stock

Treasury Stock

Additional Paid-In Capital

Accumulated Deficit

Total

Balance at Dec. 31, 2022

$ 758

$ 43,774

$ 10,714,366

$ (10,162,822)

$ 596,076

Balance (in Shares) at Dec. 31, 2022

7,576,999

^[1]

437,735,093

^[1]

Return of founders shares to the Company as part of claim settlement

$ (33,096)

$ 33,096

Return of founders shares to the Company as part of claim settlement (in Shares)

^[1]

(330,952,906)

^[1]

330,952,906

Private Placement Investment, net of issuance costs ($571,796)

$ 289

$ 18,636

4,634,279

4,653,204

Private Placement Investment, net of issuance costs ($571,796) (in Shares)

^[1]

2,886,364

186,363,631

Settlement of Treasury Stock prior to recapitalization

$ (33,096)

33,096

Settlement of Treasury Stock prior to recapitalization (in Shares)

^[1]

(330,952,906)

Reverse re-capitalization

$ 20,231

(793,497)

(773,266)

Reverse re-capitalization (in Shares)

^[1]

202,308,728

Stock-based compensation

2,253,793

Stock-based compensation (in Shares)

^[1]

Net loss

(3,567,883)

Balance at Dec. 31, 2023

$ 1,047

$ 49,545

16,842,037

(13,730,705)

3,161,924

Balance (in Shares) at Dec. 31, 2023

10,463,363

^[1]

495,454,546

^[1]

Stock-based compensation

537,197

Net loss

(1,308,463)

Balance at Mar. 31, 2024

$ 1,047

$ 49,545

17,379,234

(15,039,168)

2,390,658

Balance (in Shares) at Mar. 31, 2024

10,463,363

495,454,546

Balance at Dec. 31, 2023

$ 1,047

$ 49,545

16,842,037

(13,730,705)

3,161,924

Balance (in Shares) at Dec. 31, 2023

10,463,363

^[1]

495,454,546

^[1]

Stock-based compensation

2,246,033

Stock-based compensation (in Shares)

^[1]

Conversion of Series A Preferred Stock into Common Stock

$ (462)

$ 46,154

(45,692)

Conversion of Series A Preferred Stock into Common Stock (in Shares)

^[1]

(4,615,426)

461,542,570

Net loss

(5,775,951)

Balance at Dec. 31, 2024

$ 585

$ 95,699

19,042,378

(19,506,656)

(367,994)

Balance (in Shares) at Dec. 31, 2024

5,847,937

^[1]

956,997,116

^[1]

Stock-based compensation

23,193

Net loss

(576,123)

Balance at Mar. 31, 2025

$ 585

$ 95,699

$ 19,065,571

$ (20,082,779)

$ (920,924)

Balance (in Shares) at Mar. 31, 2025

5,847,937

956,997,116

[1]	The number shares of Common and Preferred A Stock outstanding were retroactively adjusted as a result of the Share Exchange. See Note 1

Dror Ortho-Design, Inc. S-1/A